2. Board of Directors MBA, FCA Chartered accountant: PWC Management consultancy: Reed Cons. Managing and Financial Director Juliane Klein MBA Business and Marketing gExeter University 5 years Marketing at Unilever gLondon MD University of Sao Paulo, MBA gHarvard University 8 years Head of Department of Clinical gScience PhD in Human Physiology gNewcastle University 6 years postdoctoral experience R&D Director Matthew Wilcox Marketing Director Laura Pascoe Operations Director Alessandra S. Dantas

3. Research and Development Tablet that you take before your main meal Forms a gel in the stomach Gives the feeling fullness Weight loss Reduction in bile re-uptake Therefore lowers cholesterol

4. Intellectual Property Time Line 2006200520082007 University File Patent University File for PCT Prosecute in US, Canada, Europe, Japan, China and India UK Patent Granted

5. Pipe Line Product Line ▫Different Vehicles for Administration ▫Different Flavours ▫Different Doses Product Range ▫Diabetes prevention and control ▫Specific cholesterol lowering ▫Inhibition of Dietary Enzymes

6. Marketing and Sales Strategy

7. Overview, Drivers & Competition Source: 200 16+ males and females interviewed Newcastle and London Food and supplement market £75 billion in Europe

8. Sales Strategy 1 Million trial packs Loss leader- viral marketing Letters of intent

9. Operations

10. Operations - Production and Distribution Strategies INDIA Macclesfield Nottingham

11. Operations Structure of Fybre ltd. Operations Director Warehouse LiaisingOutsourced Services FastEffects Designs Strain-Keville Solicitors WebZing Sidhartha, Vergesi Rimanshu-India TFL- Macclesfield Eddie Stobart ltd.

12. 1 1-3 4-7 8 Timeline and Milestones for Production of 1 million sample packets of Accelerol ® Buy in & shipment of raw material for WeightWatchers trial Stock piling and initial distribution to Boots, intensive advertising Months Accelerol® pressing and distribution to WeightWatchers trial Accelerol ® available to purchase from Boots nationwide

13. Financial Projections

14. Your Investment Personal investment: £20,000/Director 200820102007 Company set up (Ltd.) and University buy out: £80,000 (pref. shares) + 10% company Company Equity Share £80,000 for patent applications in Europe, USA, Canada, Japan, China, India Possible exit through IPO or Trade Sale Start of product trial through health clubs, Quality assurance Start of large scale production and product launch UK Initial Investment: £800,000 for 40% equity 2011 Closing negotiations for whole sale to Danone, Unilever, Nestle 2009 BBSRC Entrepreneur Fellowship 1NE Research and Development Grant £100,000 2012 2013 22.5% 10%

15. Financial Projections Production cost/unit: £0.50 Unit price whole sale: £2.50 Company value after 5 years: £31 M Year 1Year 2Year 3Year 4Year 5 £795.000£7.7M£12.6M£17.5M£28.5M

16. Thank You Sponsored by:

17. Balance Sheet Fybre ltd..xls

18. Cash Flow Fybre ltd.xls